Your browser version may not work well with NCBI's Web applications. More information here...
1: Oncol Nurs Forum. 1994 Oct;21(9):1504-11.Links

Prostate cancer prevention: risk reduction through life-style, diet, and chemoprevention.

Greco KE, Kulawiak L.

Cancer Prevention/Early Detection Service, Legacy Health System, Portland, OR.

PURPOSE/OBJECTIVES: To provide an overview of factors related to life-style, diet, and chemoprevention agents that may help lower the incidence of prostate cancer in the future. DATA SOURCES: Analysis of literature from MEDLINE (National Library of Medicine, Bethesda, MD), published journal articles, papers from journal bibliographies, and protocol of the Southwest Oncology Group Prostate Cancer Prevention Trial. DATA SYNTHESIS: Information related to prostate cancer prevention is accumulating, which may lead to a decreased disease incidence. Promising areas include use of chemoprevention, identification of life-style and dietary factors that may affect prostate cancer risk, and identification of genetic factors involved in prostatic carcinogenesis. CONCLUSIONS: Increased understanding of hormonal and genetic changes that occur during prostatic carcinogenesis may lead to effective methods of preventing this disease. Prostate cancer risk may be reduced by altering life-style and dietary factors and by using chemoprevention agents. IMPLICATIONS FOR NURSING PRACTICE: Oncology nurses play an important role in prostate cancer prevention through cancer risk assessment and patient and public education related to risk-reduction strategies.

PMID: 7816677 [PubMed - indexed for MEDLINE]

Related Articles

Patient Drug Information
  • Finasteride (Proscar®) Finasteride is used alone or in combination with other medications to treat benign prostatic hypertrophy (BPH, enlargement of the prostate gland). Finasteride improves symptoms of BPH such as frequent and difficult urina...
    » read more ...